Artivion Acquires Endospan to Expand Aortic Arch Portfolio
May 18, 2026
Artivion, Inc. has completed the acquisition of Endospan Ltd., following U.S. FDA PMA approval of the NEXUS Aortic Arch System. The deal includes a $135 million upfront net purchase price (plus purchase price adjustments/offsets for previously provided loans) and potential additional consideration up to $200 million tied to U.S. commercial performance over the next two years.
- Buyers
- Artivion, Inc.
- Targets
- Endospan Ltd., Endospan
- Industry
- Medical Devices
- Location
- Israel
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.